99热爱精品在线观看,人妻av中文字幕精品久久久,高清免费不卡一二三区视频,中文文字字幕视频制作,99久久国产精品热88人妻,在线不卡av片免费观看,欧美成人午夜在线观看,日韩制服丝袜中文字幕,亚洲国产精品av在线观看

Avatar
Miss Maggie Liu
Address:
Economic Development Zone, Guang'an, Sichuan, China
Telephone:
Zip Code:
Fax:
Please sign in to view contact details
Account Registered in:
2025
Business Range:
Agriculture & Food, Health & Medicine
Business Type:
Manufacturer/Factory

Company Introduction

Production Capacity

Sichuan Dingke Pharmaceuticals Co., Ltd. Was established in Sep. 2022 and is a high-tech enterprise majority-owned by Chongqing Xieran Pharma. We specialize in the R&D, manufacturing, and sales of pharmaceutical

Intermediates, active pharmaceutical ingredients (APIs), finished dosages, and cosmetic raw materials.

Guided by our core values of dedication, resilience, innovation, and shared
...
Sichuan Dingke Pharmaceuticals Co., Ltd. Was established in Sep. 2022 and is a high-tech enterprise majority-owned by Chongqing Xieran Pharma. We specialize in the R&D, manufacturing, and sales of pharmaceutical

Intermediates, active pharmaceutical ingredients (APIs), finished dosages, and cosmetic raw materials.

Guided by our core values of dedication, resilience, innovation, and shared

Success, we are deeply focused on advancing the field of APIs and specialized fine chemicals. Our mission is to become a leading supplier of specialty APIs in

Southwest China and a benchmark enterprise in the fields of orthopedics,

Dermatology, and neuropsychiatric medications across the domestic market.

Our manufacturing facility is located in the Yuechi County Pharmaceutical Industrial Park in Guang'an City, Sichuan Province. The site spans approximately 148, 666

Square meters, with a total planned investment of around USD 415 million. The

Project follows a phased construction strategy aligned with a comprehensive

Development plan, with full completion expected within five years.

Once fully operational, the facility will house 11 production workshops for APIs and

Intermediates, along with one integrated formulation workshop. The site is designed to achieve an annual production capacity of over 5, 000 metric tons of APIs and

Pharmaceutical intermediates. Phase I of the project is scheduled to be completed

And enter operation by August 2025, with commercial production and sales targeted by the end of the year.
Factory Address:
Economic Development Zone, Guang'an, Sichuan, China